CARE Ratings growth ratios

·Banking & FinanceChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY22 and earlierAlpha Plus
+17.6%+21.3%+18.9%
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
+27.1%+38.5%+12.9%
+27.4%+41.3%+14.5%
+24.1%+36.5%+20.0%
+24.3%+35.9%+19.9%
+15.3%+13.8%+9.2%
+15.6%+12.5%+6.7%
+20.1%+35.3%+10.5%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

CARERATING₹1,620.20

CARE Ratings Limited

· Banking & Finance
₹ CrorePeersICRAMcap ₹4,868 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
Revenue Growth—+18.9+21.3+17.6—
EBITDA Growth—+12.9+38.5+27.1—
EBIT Growth—+14.5+41.3+27.4—
Net Income Growth—+20.0+36.5+24.1—
EPS Growth—+19.9+35.9+24.3—
Total Assets Growth—+9.2+13.8+15.3—
Total Equity Growth—+6.7+12.5+15.6—
Cash from Operations Growth—+10.5+35.3+20.1—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.